Medpace Current Ratio from 2010 to 2024
| MEDP Stock | USD 374.32 8.12 2.12% |
Current Ratio | First Reported 2010-12-31 | Previous Quarter 0.64188531 | Current Value 0.9 | Quarterly Volatility 0.2114036 |
Check Medpace Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medpace main balance sheet or income statement drivers, such as Depreciation And Amortization of 28.5 M, Total Revenue of 2 B or Gross Profit of 278.6 M, as well as many exotic indicators such as Price To Sales Ratio of 3.3, Dividend Yield of 0.0011 or PTB Ratio of 17.69. Medpace financial statements analysis is a perfect complement when working with Medpace Holdings Valuation or Volatility modules.
Medpace | Current Ratio |
Latest Medpace Holdings' Current Ratio Growth Pattern
Below is the plot of the Current Ratio of Medpace Holdings over the last few years. It is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. Medpace Holdings' Current Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medpace Holdings' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.41 X | 10 Years Trend |
|
Current Ratio |
| Timeline |
Medpace Current Ratio Regression Statistics
| Arithmetic Mean | 0.87 | |
| Geometric Mean | 0.84 | |
| Coefficient Of Variation | 24.30 | |
| Mean Deviation | 0.17 | |
| Median | 0.92 | |
| Standard Deviation | 0.21 | |
| Sample Variance | 0.04 | |
| Range | 0.8243 | |
| R-Value | (0.32) | |
| Mean Square Error | 0.04 | |
| R-Squared | 0.1 | |
| Significance | 0.25 | |
| Slope | (0.01) | |
| Total Sum of Squares | 0.63 |
Medpace Current Ratio History
About Medpace Holdings Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Medpace Holdings income statement, its balance sheet, and the statement of cash flows. Medpace Holdings investors use historical funamental indicators, such as Medpace Holdings's Current Ratio, to determine how well the company is positioned to perform in the future. Although Medpace Holdings investors may use each financial statement separately, they are all related. The changes in Medpace Holdings's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Medpace Holdings's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Medpace Holdings Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Medpace Holdings. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 0.64 | 0.90 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Medpace Holdings Correlation against competitors. To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.Note that the Medpace Holdings information on this page should be used as a complementary analysis to other Medpace Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Medpace Stock analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Medpace Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.165 | Earnings Share 8.87 | Revenue Per Share 61.384 | Quarterly Revenue Growth 0.265 | Return On Assets 0.1399 |
The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.